{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T11:52:14Z","timestamp":1695037934887},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ancard.2016.04.003","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T17:13:13Z","timestamp":1463073193000},"page":"191-196","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pr\u00e9valence de l\u2019hypertension art\u00e9rielle r\u00e9sistante chez des hypertendus non contr\u00f4l\u00e9s adress\u00e9s dans un centre de soins tertiaires"],"prefix":"10.1016","volume":"65","author":[{"given":"N.","family":"Henine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kichou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kichou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Benbouabdellah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Boubchir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Madiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hammouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Saheb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ancard.2016.04.003_bib0095","first-page":"2159","article-title":"2013\u00a0ESH\/ESC guidelines for the management of arterial hypertension","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ancard.2016.04.003_bib0100","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/heartjnl-2011-300741","article-title":"Resistant hypertension","volume":"98","author":"Fagard","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.ancard.2016.04.003_bib0105","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients","volume":"125","author":"Daugherty","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2016.04.003_bib0110","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ancard.2016.04.003_bib0115","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(14)61942-5","article-title":"Optimum and stepped care standardized antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicenter, open-label, randomized controlled trial","volume":"385","author":"Azizi","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ancard.2016.04.003_bib0120","doi-asserted-by":"crossref","first-page":"d4891","DOI":"10.1136\/bmj.d4891","article-title":"Management of hypertension: summary of NICE guidance","volume":"343","author":"Krause","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ancard.2016.04.003_bib0125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jash.2008.12.004","article-title":"Six-item self-administererd questionnaires in the waiting room: an aid to explain uncontrolled hypertension in high-risk patients seen in general practice","volume":"3","author":"Mulazzi","year":"2009","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.ancard.2016.04.003_bib0130","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/HJH.0b013e32834c465d","article-title":"Drug-related hypertension and resistance to antihypertensive treatment: a call for action","volume":"29","author":"Rossi","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.ancard.2016.04.003_bib0135","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/ajh\/hpt132","article-title":"Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients","volume":"26","author":"Hayek","year":"2013","journal-title":"Am J Hypertens"},{"issue":"57","key":"10.1016\/j.ancard.2016.04.003_bib0140","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","article-title":"Prevalence of resistant hypertension in the United States, 2003\u20132008","volume":"6","author":"Persell","year":"2011","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.ancard.2016.04.003_bib0145","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1097\/HJH.0b013e32834a8a42","article-title":"Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT): a risk score to identify those at high risk","volume":"29","author":"Gupta","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.ancard.2016.04.003_bib0150","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/HYPERTENSIONAHA.113.01448","article-title":"Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network","volume":"62","author":"Egan","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ancard.2016.04.003_bib0155","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ancard.2013.04.011","article-title":"\u00c9volution dans l\u2019usage des traitements antihypertenseurs en France entre 2002\u00a0et 2012\u00a0: enqu\u00eates FLASH","volume":"62","author":"Gired","year":"2013","journal-title":"Ann Cardiol Angeiol"},{"issue":"7653","key":"10.1016\/j.ancard.2016.04.003_bib0160","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","article-title":"Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories","volume":"336","author":"Vrijens","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ancard.2016.04.003_bib0165","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/HJH.0b013e32835e2286","article-title":"Resistant hypertension. Assessment of adherence by toxicological urine analysis","volume":"31","author":"Jung","year":"2013","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.ancard.2016.04.003_bib0170","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","article-title":"Clinical features of 8295\u00a0patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring","volume":"57","author":"de la Sierra","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ancard.2016.04.003_bib0175","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.169961","article-title":"Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial","volume":"57","author":"Vaclavik","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ancard.2016.04.003_bib0090","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomized, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"}],"container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392816302943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392816302943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T02:59:03Z","timestamp":1536721143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003392816302943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0003392816302943"],"URL":"https:\/\/doi.org\/10.1016\/j.ancard.2016.04.003","relation":{},"ISSN":["0003-3928"],"issn-type":[{"value":"0003-3928","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pr\u00e9valence de l\u2019hypertension art\u00e9rielle r\u00e9sistante chez des hypertendus non contr\u00f4l\u00e9s adress\u00e9s dans un centre de soins tertiaires","name":"articletitle","label":"Article Title"},{"value":"Annales de Cardiologie et d'Ang\u00e9iologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ancard.2016.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}